USANA Health Sciences Inc (USNA)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 532,109 | 533,087 | 512,208 | 499,988 | 497,202 | 470,394 | 468,824 | 455,354 | 434,472 | 411,099 | 403,681 | 389,946 | 395,124 | 399,079 | 418,623 | 402,777 | 441,650 | 389,117 | 349,076 | 317,608 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $532,109K
= 0.00
The debt-to-equity ratio for USANA Health Sciences Inc has been consistently reported as 0.00 for all periods from March 31, 2020, to December 31, 2024. This indicates that the company has not reported any debt on its balance sheet during this time frame, or that its debt levels are negligible in comparison to its equity. A debt-to-equity ratio of 0.00 suggests that the company relies more on equity financing rather than debt financing to fund its operations and investment activities. This could be viewed positively by investors and creditors as it signifies a lower financial risk and a stronger financial position for the company. However, it is important to consider other financial metrics and factors when evaluating the overall financial health and performance of USANA Health Sciences Inc.